Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Alphafetoprotein: an obituary.

Sherman M.

J Hepatol. 2001 Apr;34(4):603-5. No abstract available.

PMID:
11394662
[PubMed - indexed for MEDLINE]
2.

Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.

Ho S, Cheng P, Yuen J, Chan A, Leung N, Yeo W, Leung T, Lau WY, Li AK, Johnson PJ.

Br J Cancer. 1996 Apr;73(8):985-8.

PMID:
8611436
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation: carcinoembryonic antigen (CEA) and alphafetoprotein (AFP) as tumor markers of the liver.

Barroso A, Alpert E.

Lab Res Methods Biol Med. 1983;7:153-7. Review. No abstract available.

PMID:
6194396
[PubMed - indexed for MEDLINE]
4.

[alpha-1 fetoproteins in the diagnosis of hepatoma and teratogenic neoplasms].

Lehmann FG.

Med Lab (Stuttg). 1977 Apr;30(4):87-99. German. No abstract available.

PMID:
69254
[PubMed - indexed for MEDLINE]
5.

Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma.

Aoyagi Y, Isemura M, Suzuki Y, Sekine C, Soga K, Ozaki T, Ichida F.

Lancet. 1985 Dec 14;2(8468):1353-4. No abstract available.

PMID:
2415789
[PubMed - indexed for MEDLINE]
6.

Hepatocellular carcinoma.

Neill P.

Cent Afr J Med. 1987 Mar;33(3):85-6. No abstract available.

PMID:
2448042
[PubMed - indexed for MEDLINE]
7.

Occult hepatocellular carcinoma with high fucosylated alpha-fetoprotein.

Terada R, Yamamoto K, Sakaguchi K, Kiyotoshi S, Yagi T, Sadamori H, Tsuji T.

J Gastroenterol Hepatol. 2001 Nov;16(11):1310-1. No abstract available.

PMID:
11903755
[PubMed - indexed for MEDLINE]
8.

[Clinical evaluation of alpha-fetoprotein as tumor marker for hepatocellular carcinoma (author's transl)].

Tang ZY, Yang BH.

Zhonghua Zhong Liu Za Zhi. 1981 Aug;3(3):205-9. Chinese. No abstract available.

PMID:
6175491
[PubMed - indexed for MEDLINE]
9.

[Assay of alpha-fetoprotein by monoclonal antibodies: progress in the diagnosis of hepatocellular carcinoma?].

Bergman JF, Labadie H, Beaugrand M.

Gastroenterol Clin Biol. 1985 Oct;9(10):742. French. No abstract available.

PMID:
2415422
[PubMed - indexed for MEDLINE]
10.

Hepatocellular carcinoma: available diagnostic tools and their limitations.

Parvez T, Gumgumji AA, Raddadi MA, Rufai AA, Sabir AA, Ibraheim MI.

J Coll Physicians Surg Pak. 2004 Jan;14(1):57-60. Review. No abstract available.

PMID:
14764268
[PubMed - indexed for MEDLINE]
11.

Alpha-fetoprotein and hepatocellular carcinoma.

Colli A, Fraquelli M, Conte D.

Am J Gastroenterol. 2006 Aug;101(8):1939; author reply 1940-1. No abstract available.

PMID:
16928257
[PubMed - indexed for MEDLINE]
12.

Hepatoma associated protein.

[No authors listed]

J Assoc Physicians India. 1979 Apr;27(4):340-3. No abstract available.

PMID:
93600
[PubMed - indexed for MEDLINE]
13.

Alpha-fetoprotein testing in Papua New Guinea.

Booth PB.

P N G Med J. 1977 Sep;20(3):144. No abstract available.

PMID:
79275
[PubMed - indexed for MEDLINE]
14.

Research on high risk groups of primary hepatocellular carcinoma (PHC).

Yu LY.

Prog Clin Biol Res. 1983;132E:475-82. No abstract available.

PMID:
6196791
[PubMed - indexed for MEDLINE]
15.

Surveillance for hepatocellular carcinoma.

Aqel BA, Ho SB.

Postgrad Med. 2006 Sep-Oct;119(3):19-24. Review. No abstract available.

PMID:
17128641
[PubMed - indexed for MEDLINE]
16.

Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.

Li X, Wu K, Fan D.

Hepatology. 2009 Jul;50(1):325. doi: 10.1002/hep.23028. No abstract available. Corrected and republished in: Hepatology. 2009 Nov;50(5):1682.

PMID:
19492428
[PubMed - indexed for MEDLINE]
17.

Hepatocellular carcinoma.

Smith AD, Dunk AA, Tuttle-Newhall JE, Trotter JF.

Lancet. 2004 Mar 13;363(9412):898-9. No abstract available.

PMID:
15031047
[PubMed - indexed for MEDLINE]
18.

[The application of serum tumor markers in the diagnosis of hepatocellular carcinoma].

Liao HY.

Zhonghua Gan Zang Bing Za Zhi. 2005 May;13(5):379-80. Chinese. No abstract available.

PMID:
15918977
[PubMed - indexed for MEDLINE]
19.

Tumour markers in the diagnosis and management of patients with hepatocellular carcinoma.

Johnson PJ.

Recent Results Cancer Res. 1986;100:68-72. No abstract available.

PMID:
2426745
[PubMed - indexed for MEDLINE]
20.

Reference change value for alpha-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease.

Trapé J, Botargues JM, Porta F, Ricós C, Badal JM, Salinas R, Sala M, Roca A.

Clin Chem. 2003 Jul;49(7):1209-11. No abstract available.

PMID:
12816928
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk